Concepedia

Pharmacovigilance Data Integration

Pharmacovigilance Data Integration is a methodological framework that systematically combines disparate safety data sources from preclinical, clinical, and post-marketing surveillance domains to enable unified detection, assessment, and monitoring of adverse drug reactions within the broader context of pharmaceutical data integration.

25

Publications

1K

Citations

128

Authors

68

Institutions

Publications per year

2017–2026

13

Parents

Publications

25

OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications

Ruwen Böhm, Leocadie von Hehn, Thomas Herdegen et al. · PLoS ONE · 2016 · 254 citations · Full text

, , +16

DrugCentral 2023 extends human clinical data and integrates veterinary drugs

Sorin Avram, Thomas B. Wilson, Ramona Curpăn et al. · Nucleic Acids Research · 2022 · 89 citations · Full text

, , +15

Artificial Intelligence and the Future of the Drug Safety Professional

Karolina Danysz, Salvatore Cicirello, Edward Mingle et al. · Drug Safety · 2018 · 63 citations · Full text

, , +16

Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis

Zeyun Zhou, Kyle E. Hultgren · JMIR Public Health and Surveillance · 2020 · 53 citations · Full text

, , +16

Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives

Zhengwu Lu · Drug Healthcare and Patient Safety · 2009 · 51 citations · Full text

, , +17

1–5 of 25

Authors

128

  1. FS
    Ferrán Sanz

    Universitat Pompeu Fabra, Spain

    2 publications · 68 citations

    2

    h-index

  2. SB
    Scott Boyer

    AstraZeneca (Sweden), Sweden

    2 publications · 68 citations

    2

    h-index

  3. LI
    Laura I. Furlong

    Universitat Pompeu Fabra, Spain

    2 publications · 68 citations

    2

    h-index

  4. PA
    Paul Avillach

    Harvard University, United States

    2 publications · 68 citations

    2

    h-index

  5. PL
    Pedro Lopes

    University of Aveiro, Portugal

    2 publications · 68 citations

    2

    h-index

1–5 of 128

Institutions

68

  1. Université de Bordeaux

    Bordeaux, France

    2 h-index

    4 publications

    136 citations

  2. AstraZeneca (Sweden)

    Södertälje, Sweden

    2 h-index

    4 publications

    136 citations

  3. Erasmus MC

    Rotterdam, The Netherlands

    2 h-index

    8 publications

    272 citations

  4. Municipal Institute for Medical Research

    Barcelona, Spain

    2 h-index

    10 publications

    340 citations

  5. European Medicines Agency

    Amsterdam, Netherlands

    2 h-index

    3 publications

    84 citations

  6. Aix-Marseille Université

    Marseille, France

    2 h-index

    2 publications

    68 citations

  7. University of Aveiro

    Aveiro, Portugal

    2 h-index

    8 publications

    272 citations

  8. Universitat Pompeu Fabra

    Barcelona, Spain

    2 h-index

    10 publications

    340 citations

1–8 of 68

Venues

  1. Drug Safety

    3 publications · 135 citations

    3

    h-index

  2. PLoS ONE

    2 publications · 276 citations

    2

    h-index

  3. Clinical Pharmacology & Therapeutics

    CPT · 2 publications · 73 citations

    2

    h-index

  4. Journal of Clinical Psychopharmacology

    1 publications · 12 citations

    1

    h-index

  5. Drugs in R&D

    1 publications · 13 citations

    1

    h-index

1–5